{"&cites=8112066538378712761&as_sdt=2005&sciodt=0,5&hl=en":[{"title":"Prices, costs, and affordability of new medicines for hepatitis C in 30 countries: an economic analysis","url":"https://journals.plos.org/plosmedicine/article?id=10.1371/journal.pmed.1002032","authors":["S Iyengar","S Iyengar K Tay"],"year":2016,"numCitations":201,"pdf":"https://journals.plos.org/plosmedicine/article?id=10.1371/journal.pmed.1002032","citationUrl":"http://scholar.google.com/scholar?cites=7832401979471289488&as_sdt=2005&sciodt=0,5&hl=en","relatedUrl":"http://scholar.google.com/scholar?q=related:kNxzPBpIsmwJ:scholar.google.com/&scioq=&hl=en&as_sdt=2005&sciodt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=7832401979471289488&hl=en&as_sdt=2005&sciodt=0,5","publication":"journals.plos.org","p":1,"exp":1596876810208},{"title":"Cost-containment policies in public pharmaceutical spending in the EU","url":"https://papers.ssrn.com/sol3/papers.cfm?abstract_id=2161803","authors":["G Carone","G Carone C Schwierz","G Carone C Schwierz A Xavier"],"year":2012,"numCitations":184,"pdf":"https://mpra.ub.uni-muenchen.de/42008/1/MPRA_paper_42008.pdf","citationUrl":"http://scholar.google.com/scholar?cites=13065636972614623387&as_sdt=2005&sciodt=0,5&hl=en","relatedUrl":"http://scholar.google.com/scholar?q=related:m6DnFJp3UrUJ:scholar.google.com/&scioq=&hl=en&as_sdt=2005&sciodt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=13065636972614623387&hl=en&as_sdt=2005&sciodt=0,5","publication":"papers.ssrn.com"},{"title":"The impact of pharmaceutical pricing and reimbursement policies on generics uptake: implementation of policy options on generics in 29 European countries …","url":"http://gabi-journal.net/wp-content/uploads/GJ-2012-2-p93-100-SpecialReport-Vogler.pdf","authors":["S Vogler"],"year":2012,"numCitations":151,"pdf":"http://gabi-journal.net/wp-content/uploads/GJ-2012-2-p93-100-SpecialReport-Vogler.pdf","citationUrl":"http://scholar.google.com/scholar?cites=2113961910240874437&as_sdt=2005&sciodt=0,5&hl=en","relatedUrl":"http://scholar.google.com/scholar?q=related:xQ-dOChNVh0J:scholar.google.com/&scioq=&hl=en&as_sdt=2005&sciodt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=2113961910240874437&hl=en&as_sdt=2005&sciodt=0,5","publication":"gabi-journal.net"},{"title":"Cancer drugs in 16 European countries, Australia, and New Zealand: a cross-country price comparison study","url":"https://www.sciencedirect.com/science/article/pii/S1470204515004490","authors":["S Vogler","S Vogler A Vitry"],"year":2016,"numCitations":132,"pdf":"https://www.lesdebatspublicsdelipc.com/wp-content/uploads/2015/12/price-countries.pdf","citationUrl":"http://scholar.google.com/scholar?cites=14822251102123917904&as_sdt=2005&sciodt=0,5&hl=en","relatedUrl":"http://scholar.google.com/scholar?q=related:UAK9gdg2s80J:scholar.google.com/&scioq=&hl=en&as_sdt=2005&sciodt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=14822251102123917904&hl=en&as_sdt=2005&sciodt=0,5","publication":"Elsevier"},{"title":"Reforms in the Greek pharmaceutical market during the financial crisis","url":"https://www.sciencedirect.com/science/article/pii/S0168851012002254","authors":["S Vandoros","S Vandoros T Stargardt"],"year":2013,"numCitations":94,"pdf":"https://www.hche.de/de/bilder/newsletter/Vandoros-Stargardt-2013---Reforms-in-the-Greek-pharmaceutical-market.pdf","citationUrl":"http://scholar.google.com/scholar?cites=14658163475182557512&as_sdt=2005&sciodt=0,5&hl=en","relatedUrl":"http://scholar.google.com/scholar?q=related:SJnctQRCbMsJ:scholar.google.com/&scioq=&hl=en&as_sdt=2005&sciodt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=14658163475182557512&hl=en&as_sdt=2005&sciodt=0,5","publication":"Elsevier"},{"title":"Discounts and rebates granted to public payers for medicines in European countries","url":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3471187/","authors":["S Vogler","S Vogler N Zimmermann","S Vogler N Zimmermann C Habl…"],"year":2012,"numCitations":89,"pdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3471187/","citationUrl":"http://scholar.google.com/scholar?cites=3121680952657032052&as_sdt=2005&sciodt=0,5&hl=en","relatedUrl":"http://scholar.google.com/scholar?q=related:dLM5fUlwUisJ:scholar.google.com/&scioq=&hl=en&as_sdt=2005&sciodt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=3121680952657032052&hl=en&as_sdt=2005&sciodt=0,5","publication":"ncbi.nlm.nih.gov"},{"title":"Ongoing initiatives to improve the quality and efficiency of medicine use within the public healthcare system in South Africa; a preliminary study","url":"https://www.frontiersin.org/articles/10.3389/fphar.2017.00751/full","authors":["JC Meyer","JC Meyer N Schellack","JC Meyer N Schellack J Stokes","JC Meyer N Schellack J Stokes R Lancaster…"],"year":2017,"numCitations":65,"pdf":"https://www.frontiersin.org/articles/10.3389/fphar.2017.00751/full","citationUrl":"http://scholar.google.com/scholar?cites=8280794472328491991&as_sdt=2005&sciodt=0,5&hl=en","relatedUrl":"http://scholar.google.com/scholar?q=related:13Mo9bJK63IJ:scholar.google.com/&scioq=&hl=en&as_sdt=2005&sciodt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=8280794472328491991&hl=en&as_sdt=2005&sciodt=0,5","publication":"frontiersin.org"},{"title":"Policy options for pharmaceutical pricing and purchasing: issues for low-and middle-income countries","url":"https://academic.oup.com/heapol/article-abstract/30/2/267/618341","authors":["TA Nguyen","TA Nguyen R Knight","TA Nguyen R Knight EE Roughead…"],"year":2015,"numCitations":61,"pdf":"https://academic.oup.com/heapol/article/30/2/267/618341","citationUrl":"http://scholar.google.com/scholar?cites=8191893070759889212&as_sdt=2005&sciodt=0,5&hl=en","relatedUrl":"http://scholar.google.com/scholar?q=related:PImgaFhzr3EJ:scholar.google.com/&scioq=&hl=en&as_sdt=2005&sciodt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=8191893070759889212&hl=en&as_sdt=2005&sciodt=0,5","publication":"academic.oup.com"},{"title":"Generic medicines: solutions for a sustainable drug market?","url":"https://link.springer.com/article/10.1007/s40258-013-0043-z","authors":["P Dylst","P Dylst A Vulto","P Dylst A Vulto B Godman","P Dylst A Vulto B Godman S Simoens"],"year":2013,"numCitations":59,"pdf":"https://www.researchgate.net/profile/Arnold_Vulto/publication/248705372_Generic_Medicines_Solutions_for_a_Sustainable_Drug_Market/links/5dbd96c6a6fdcc2128fd5f96/Generic-Medicines-Solutions-for-a-Sustainable-Drug-Market.pdf","citationUrl":"http://scholar.google.com/scholar?cites=3364640068123856534&as_sdt=2005&sciodt=0,5&hl=en","relatedUrl":"http://scholar.google.com/scholar?q=related:lo6RuVCasS4J:scholar.google.com/&scioq=&hl=en&as_sdt=2005&sciodt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=3364640068123856534&hl=en&as_sdt=2005&sciodt=0,5","publication":"Springer"}]}